Publication: 2022 American college of rheumatology/EULAR classification criteria for giant cell arteritis
Loading...
Files
Date
2022-12-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Objective: To develop and validate updated classification criteria for giant cell arteritis (GCA). Methods: Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 6 phases: 1) identification of candidate items, 2) prospective collection of candidate items present at the time of diagnosis, 3) expert panel review of cases, 4) data-driven reduction of candidate items, 5) derivation of a points-based risk classification score in a development data set, and 6) validation in an independent data set. Results: The development data set consisted of 518 cases of GCA and 536 comparators. The validation data set consisted of 238 cases of GCA and 213 comparators. Age ≥50 years at diagnosis was an absolute requirement for classification. The final criteria items and weights were as follows: positive temporal artery biopsy or temporal artery halo sign on ultrasound (+5); erythrocyte sedimentation rate ≥50 mm/hour or C-reactive protein ≥10 mg/liter (+3); sudden visual loss (+3); morning stiffness in shoulders or neck, jaw or tongue claudication, new temporal headache, scalp tenderness, temporal artery abnormality on vascular examination, bilateral axillary involvement on imaging, and fluorodeoxyglucose–positron emission tomography activity throughout the aorta (+2 each). A patient could be classified as having GCA with a cumulative score of ≥6 points. When these criteria were tested in the validation data set, the model area under the curve was 0.91 (95% confidence interval [95% CI] 0.88–0.94) with a sensitivity of 87.0% (95% CI 82.0–91.0%) and specificity of 94.8% (95% CI 91.0–97.4%). Conclusion: The 2022 American College of Rheumatology/EULAR GCA classification criteria are now validated for use in clinical research.
Description
Keywords
Tıp, Dahili Tıp Bilimleri, İç Hastalıkları, İmmünoloji ve Romatoloji, Yaşam Bilimleri, Sağlık Bilimleri, Temel Bilimler, Medicine, Internal Medicine Sciences, Internal Diseases, Immunology and Rheumatology, Life Sciences, Health Sciences, Natural Sciences, Klinik Tıp (MED), Yaşam Bilimleri (LIFE), Klinik Tıp, İmmünoloji, ALERJİ, ROMATOLOJİ, Clinical Medicine (MED), Life Sciences (LIFE), CLINICAL MEDICINE, IMMUNOLOGY, ALLERGY, RHEUMATOLOGY, İmmünoloji ve Alerji, Romatoloji, Immunology and Allergy, Rheumatology, Immunology
Citation
Ponte C., Grayson P. C., Robson J. C., Gribbons K. B., Judge A., Craven A., Khalid S., Hutchings A., Watts R. A., Merkel P. A., et al., "2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis", Arthritis and Rheumatology, cilt.74, sa.12, ss.1881-1889, 2022